Report Categories
View AllRecent Articles
View All
Phillips 66 PSX Dividend Sustainability and Value Prospects Amid 2026 Bear Market Volatility
OLLI Ollies reports 166 percent year over year revenue gain falls 266 percent on minor EPS miss
Humana Inc HUM Lowered 2026 EPS Guidance Signals NearTerm Earnings Pressure Amid Medicare Advantage Headwinds
Halliburton Co HAL Q1 2026 Earnings Beat Drives SectorWide Bullish Sentiment Lifting Peer ProPetro PUMP
Cohen RQI Stock Target Price Flatline 20260420
What entry point for Golub GBDC Drifts Higher 20260501
What should investors watch next for Exelixis EXEL stock Exelixis posts 7 EPS beat vs analyst estimates
Why Hancock Fund BTO might be the steady performer you need Underperforming 20260508
The key driver behind CreditAccept CACC revenue growth Q1 2026 Profit Disappoints
SmallCap Biotech Stock Watch AnalystSelected Opportunities in the Emerging Therapeutics Space
Anthropic and Gates Foundation Forge 200 Million AI Partnership to Transform Health Education and Agriculture
Inflation Pressures Widen Beyond Oil These Sectors Are Seeing Price Reacceleration
GCI GLIBA Slides 237 as Selling Pressure Mounts 20260517
JBS NV JBS Q1 2026 Earnings Miss Sparks Concern
Bowman BWMN Q1 2026 Earnings Miss EPS 022 vs 009 Expected
Brazil Seeks EU Relisting on Antimicrobial Compliance Amid Meat Import Ban Surprise
Oatly OTLY Surges 122 Nearing 1047 Resistance 20260520
Shinhan Financial Group Q4 2025 Earnings EPS Miss of 35 on Higher Provisions
SPT Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Unavailable
Uranium Royalty Corp UROY Q1 2026 Earnings EPS Turns Positive Topping Estimates by 199 Stock Slips 3
Mainz Biomed QUCY Q4 2023 Earnings EPS Beat Partially Offsets Bearish Sentiment Shares Slide 65
TONX Q1 2026 Earnings EPS Beat Drives 62 Stock Gain as Losses Narrow Sharply
Alaska Air Group ALK Edges Higher Navigating Support and Resistance Levels
Navios Maritime Partners NMM Holds Steady Near Support as Shipping Sector Faces Mixed Signals
Xos Inc XOS Surges 429 as Shares Approach Key Resistance at 230
Dyne Therapeutics DYN Holds Steady at 1737 as Traders Eye Key Support and Resistance Levels